Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2C-B versus psilocybin acute and subacute profiling study
NL-OMON28125Not yet recruiting
- Sponsor
- Maastricht University
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial comparing 2C-B, psilocybin and placebo control (3 arms). Primary endpoint: Digit Symbol Substitution Task performance. Planned start Aug 2021; status: not yet recruiting.
02
Drugs
4-bromo-2,5-dimethoxyphenethylaminepsilocybin
Beyond the preview
Go deeper on NL-OMON28125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28125.